Novartis Divests Tension Headache Products in U.S.
12 févr. 2003 03h15 HE
|
Novartis
BASEL, Switzerland, Feb. 12, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS) announced today that it has sold the U.S. rights for its Fioricet(R) and Fiorinal(R) product lines to Watson Pharmaceuticals,...
Australian Pharmaceutical Industries to Implement New Core Application System from Intentia
23 janv. 2003 08h51 HE
|
Intentia
STOCKHOLM, Sweden and SYDNEY, Australia, Jan. 23, 2003 (PRIMEZONE) -- Intentia International AB (publ.) (Stockholm:INTb) (Other OTC:IAINF), one of the world's most successful suppliers of enterprise...
Innogenetics' Outlook for 2003 -- Enhanced Financial Prospects and Promising New Therapeutic Developments
15 janv. 2003 02h21 HE
|
Innogenetics
GENT, Belgium, Jan. 15, 2003 (PRIMEZONE) -- Innogenetics (Other OTC:INGTF) today announced the preliminary indications of its year 2002 financial results, offered an initial outlook for 2003 and...
Pyrosequencing to Distribute Corbett Products in the U.S.
14 janv. 2003 08h30 HE
|
Pyrosequencing
UPPSALA, Sweden, Jan. 14, 2003 (PRIMEZONE) -- Pyrosequencing AB (Stockholm:PYROa) (Other OTC:PYRSF) today reported that the Company signed an agreement to distribute Corbett Research's full line of...
Biovitrum AB Signs an Agreement with Lundbeck to Produce Protein Therapeutics
14 janv. 2003 04h13 HE
|
Biovitrum AB
STOCKHOLM, Sweden, Jan. 14, 2003 (PRIMEZONE) -- Biovitrum AB today announced a commission agreement with the Danish pharmaceutical company Lundbeck A/S for the production of a protein...
Biovitrum Signs Agreement with Lundbeck to Produce Protein Therapeutics
14 janv. 2003 04h08 HE
|
Biovitrum
STOCKHOLM, Sweden, Jan. 14, 2003 (PRIMEZONE) -- Biovitrum AB today announces a commission agreement with the Danish pharmaceutical company Lundbeck A/S for the production of a protein...
Crucell Expects Charge Related to Impairment of Goodwill
23 déc. 2002 03h24 HE
|
Crucell N.V.
LEIDEN, The Netherlands, Dec. 23, 2002 (PRIMEZONE) -- Dutch antibody and vaccine company, Crucell N.V. (Nasdaq:CRXL) today announced that it expects to record a goodwill impairment charge during the...
Sectra Announces Cooperation with European Health IT Supplier Torex
13 déc. 2002 03h43 HE
|
Sectra
LINKOPING, Sweden, Dec. 13, 2002 (PRIMEZONE) -- The Swedish IT- and medical technology company Sectra (Other OTC:SSBBF) (Stockholm:SECTb) signed a partnership agreement with U.K.-based Torex Health,...
Actelion Ltd.: European Commission Approval for Zavesca; European Launch of Type 1 Gaucher Treatment in spring 2003
26 nov. 2002 03h41 HE
|
Actelion Ltd.
ALLSCHWIL/BASEL, Switzerland and OXFORD, U.K., Nov. 26, 2002 (PRIMEZONE) -- Actelion Ltd. (SWX:ATLN) (Other OTC:ALIOF) and Oxford GlycoSciences Plc (LSE:OGS) (Nasdaq:OGSI) today announced that the...
Biacore Cell-Based Assay System Introduced
19 nov. 2002 06h15 HE
|
Biacore
UPPSALA, Sweden, Nov. 19, 2002 (PRIMEZONE) -- Biacore International AB (Biacore) (SSE:BCOR) (Nasdaq:BCOR) today announced the introduction of its new cell-based assay system at the first of a series...